Myriad Genetics (MYGN) CFO Reports 2,559 Shares Withheld to Cover Taxes

Rhea-AI Filing Summary

Benjamin R. Wheeler, Chief Financial Officer of Myriad Genetics (MYGN), reported a Form 4 showing shares withheld to cover taxes on vested restricted stock units. On 09/21/2025 the filing records 2,559 shares disposed (withheld) at an indicated price of $7.77 per share. After this withholding, Mr. Wheeler beneficially owns 92,651 shares. The filing explains the shares were withheld to satisfy tax withholding obligations and that the withheld amount was determined using Myriad's closing price on September 19, 2025.

Insights

Financial Analyst

TL;DR: Routine tax withholding on vested RSUs by the CFO; immaterial to company valuation but updates insider ownership.

The transaction is a standard administrative disposition where 2,559 shares were withheld to satisfy tax obligations tied to vested restricted stock units. This is not a market sale or signal of liquidity needs; it reduces the reporting person's direct share count to 92,651. For investors, the change is informational about insider holdings but not materially impactful to Myriad's capital structure or operations.

Corporate Governance Expert

TL;DR: Administrative withholding following RSU vesting; consistent with common executive compensation practices.

The disclosure follows expected governance practices by reporting a tax-withholding disposition and specifying the method (withheld shares) and basis (closing price on September 19, 2025). The Form 4 provides transparency on insider ownership levels. There are no indications of atypical compensation arrangements or extraordinary insider dispositions in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wheeler Benjamin Richard

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UT 84116

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/21/2025		F		2,559(1)	D	$7.77	92,651	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025.

Remarks:

	By: Justin Hunter For: Benjamin R. Wheeler	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Benjamin R. Wheeler report on the Form 4 for MYGN?

He reported withholding of 2,559 shares on 09/21/2025 to satisfy tax obligations related to vested restricted stock units; beneficial ownership after the transaction is 92,651 shares.

Why were the 2,559 Myriad (MYGN) shares disposed of?

The shares were withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock units, as stated in the filing.

At what price were the withheld Myriad (MYGN) shares determined?

The Form 4 shows a price of $7.77 per share; the number of shares withheld was determined based on the closing price on September 19, 2025.

What is Benjamin R. Wheeler's role at Myriad listed in the Form 4?

He is the Chief Financial Officer and the Form 4 indicates he filed as an officer and director where applicable.

Does this Form 4 indicate a market sale by the insider?

No. The filing specifies shares were withheld to satisfy taxes on vested RSUs, not an open-market sale.